Robotic biobanking systems market seen reaching $4.57 billion by 2030

The robotic biobanking systems market is projected to grow from $2.3 billion in 2025 to $4.57 billion by 2030, driven by rising sample volumes, precision medicine and automation in sample storage and retrieval. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The robotic biobanking systems market is expanding as labs and biorepositories face more biological samples and more pressure to store them accurately. - Automation can reduce human handling errors, improve traceability and support long-term sample integrity. - The market's growth matters for biomedical research, clinical trials and pharmaceutical development.

What happened: - The Business Research Company published a 2026 report on the global robotic biobanking systems market. - The report estimates the market will rise from $2.3 billion in 2025 to $2.65 billion in 2026. - The report projects the market will reach $4.57 billion by 2030. - The report links that forecast to a 14.9% CAGR from 2025 to 2026 and a 14.6% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Robotic biobanking systems are automated, computer-guided platforms for managing, processing and storing biological specimens with minimal human input. - The systems combine robotics, artificial intelligence and data management tools to support precise handling and secure traceability. - The technology is used in biomedical research, clinical trials and pharmaceutical development. - Key growth drivers include rising clinical research sample volumes, investments in biobanking infrastructure, demand for better sample traceability, the limits of manual storage and early automation adoption. - The forecast also points to precision medicine, genomic research, large-scale clinical trials, digital biorepository management and AI-powered sample analytics as growth drivers. - The report highlights automated sample storage and retrieval, high-throughput operations, reduced human handling errors and long-term sample integrity management as major trends. - A growing number of biological sample collections is pushing demand for robotic systems. - Those collections include blood, tissues, saliva and other biospecimens, along with related clinical data for research, diagnostics and therapeutic innovation. - Precision medicine is increasing the need for large, well-characterized repositories that can support genomic studies, biomarker identification and personalized treatment development. - UK Biobank Limited said in July 2025 that it planned to move more than 11 million samples to a new facility in Manchester in 2026. - The new Manchester site will include four automated freezers with capacity for up to 20 million samples. - The robotic systems at the site are expected to retrieve about 1 million samples per year, four times faster than current capabilities.

Between the lines: - The market forecast suggests biobanking is shifting from a storage function to a data-intensive, automated infrastructure layer for research and drug development. - Large-scale sample moves like UK Biobank's planned relocation show how inventory growth is creating practical limits for manual workflows. - The report's focus on AI and digital management signals that future competition may center on systems that connect physical storage with software-driven sample intelligence.

What's next: - The report expects demand to keep rising as precision medicine, genomics and clinical trial activity expand. - Biobanks are likely to invest more in automated storage, retrieval and traceability tools. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards and trend graphics. - More information is available through the company's announcement and social channels.